Mikhail Eydelman
Compliance Officer presso VAXCYTE, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Mikhail Eydelman is currently working as the Secretary, Chief Compliance Officer & Senior VP at Vaxcyte, Inc. Prior to his current position, he worked as the Secretary & General Counsel at Sagent Pharmaceuticals, Inc. from 2017 to 2022.
Mr. Eydelman completed his undergraduate degree at Brandeis University and his graduate degree at New York University School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VAXCYTE, INC.
0.03% | 01/04/2024 | 30 597 ( 0.03% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Mikhail Eydelman
| Società | Posizione | Inizio |
|---|---|---|
| VAXCYTE, INC. | Compliance Officer | 01/04/2022 |
Precedenti posizioni note di Mikhail Eydelman
| Società | Posizione | Fine |
|---|---|---|
| SAGENT PHARMACEUTICALS INC | General Counsel | 01/04/2022 |
Formazione di Mikhail Eydelman
| Brandeis University | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VAXCYTE, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Borsa valori
- Insiders
- Mikhail Eydelman
